Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associa

biospaceMarch 20, 2018

Tag: Boehringer Ingelheim , FDA

PharmaSources Customer Service